NexgenRx Inc
- LAST PRICE0.2900
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.2700/ 40
- Ask / Lots0.2950/ 160
- Open / Previous Close--- / 0.2900
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
NexgenRx Inc | 20.6M | -491.5x | --- |
Cathedra Bitcoin Inc | 18.4M | -23.1x | --- |
CryptoStar Corp | 15.5M | -2.8x | --- |
Flow Capital Corp | 22.4M | -33.9x | --- |
Victory Square Technologies Inc | 10.8M | -0.8x | --- |
Aberdeen International Inc | 9.5M | -0.8x | --- |
Company Information
NexgenRx Inc. is a Canada-based independent full-service third-party administrator and technology solutions provider. The Company is focused on building technology platforms that equip its clients with unprecedented capabilities for managing and self-managing group benefit plans, group pension plans and patient support programs. It offers plan sponsors, providers and patient support program/drug manufacturers a full suite of software-as-a-service solutions. The Company’s products include NexSys, NexAdmin, and NexPSPAssist. The NexSys single platform solution simplifies adjudication of dental, prescription drug and extended health claims. Its NexAdmin product enables sponsors to take complete control of benefit plan administration. NexPSPAssist service helps patient support programs (PSP) to optimize their deliverables to their manufacturer clients. Its NexPension is an advanced pension administration solution designed to help sponsors record and tabulate contributions.
Contact Information
- Headquarters
- 191 The West Mall, Suite 905TORONTO, ON, Canada M9C 5L6
- Phone
- 416-695-3393
- Fax
- 647-722-2934
Executives
- Independent Chairman of the Board
- Thomas Corcoran
- President, Chief Executive Officer, Director
- Ronald Loucks
- Chief Financial Officer
- Kelly Ehler
- Senior Vice President - Pharma and Payor Partners
- Andrew Munroe
- Director
- Linda Brennan
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $20.6M |
|---|---|
Revenue (TTM) | $15.3M |
Shares Outstanding | 71.1M |
Dividend Yield | 3.45% |
Annual Dividend Rate | 0.0100 CAD |
Ex-Dividend Date | 06-24-24 |
Pay Date | 06-30-24 |
Beta | 0.35 |
EPS | $0.00 |
Book Value | $0.11 |
P/E Ratio | -491.5x |
Price/Sales (TTM) | 1.3 |
Price/Cash Flow (TTM) | 16.4x |
Operating Margin | 0.01% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
